Join the Oncology Voice Network. Join for Free
How to overcome... "You don't have experience"
MSL career transition MSL job preparation breaking into MSL role overcoming MSL challenges MSL industry terminology

How to overcome... "You don't have experience"


Share This Article


Summary

In this episode, Mia Barnes joins Tom Caravela to discuss her journey from clinical practice to the MSL role. Mia shares insights on transitioning into the industry, highlighting the importance of working with a good recruiter and preparing effectively for job applications and interviews. They delve into overcoming common challenges faced by new MSLs, such as learning industry terminology and managing large territories. Mia emphasizes the significance of building skills, gaining exposure, and maintaining an activity journal. The conversation also touches on breaking into the MSL role with passion and specializing in specific disease states. The episode concludes with closing remarks and gratitude.

My guest today is Mia Barnes, Medical Science Liaison and we talk about how to overcome the "you don’t have enough experience" paradigm.

In this episode we discuss:

  • Mia and her background
  • Experiencing the ”You don’t have enough experience” paradigm
  • How much preparation ahead of time
  • Landing the first role and transitioning to a new team
  • Some of the things she does to establish herself in her role
  • How difficult it is to get noticed and what has worked well for Mia

Click for Source
MSL career transition, MSL job preparation, breaking into MSL role, overcoming MSL challenges, MSL industry terminology

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Mastering the Medical Affairs Professional Role: Inside and Out
Partner Avatar MSL Talk: Tom Caravela, Kent Christofferson

Mastering the Medical Affairs Professional Role: Inside and Out

Podcast
Landing My First MSL Role: From the Inside
Partner Avatar MSL Talk: Tom Caravela, Amanda Vaughn

Landing My First MSL Role: From the Inside

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
OVN Avatar R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren, A.B. Benson III

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Article
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
OVN Avatar Charles L. Bennett , Sumimasa Nagai , Andrew C. Bennett , Shamia Hoque , Chadi Nabhan , Martin W. Schoen , William J. Hrushesky , Stefano Luminari , Paul Ray , Paul R. Yarnold , Bart Witherspoon , Josh Riente , Laura Bobolts , John Brusk , Rebecca Tombles

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Explore OVN